News-Medical.Net on MSN
COVID-19 initially reduced asthma attacks but widened socioeconomic disparities, study finds
By Pooja Toshniwal Paharia A six-year analysis from a major Bronx health system reveals how the pandemic reshaped asthma ...
Dear critical reader, as humanity hurtles into the AI-era, with its many exciting positive nation-building tipping-points, ...
Drug allergy labels (DAL) are common and largely unevaluated in children with primary immunodeficiencies, which could lead to worse patient outcomes, according to new research being presented at the ...
Bank of America 2026 Global Agriculture and Materials Conference February 25, 2026 9:45 AM ESTCompany ParticipantsStephan Tanda ...
While serious complications from asthma have been on the downswing, the rise of obesity could blunt that progress. Here’s how to help your patients with obesity and asthma.
Statin use had a statistically significant protective effect against acute asthma exacerbations in mild asthma among Black ...
High medical bills, safer systems, and better quality of life are driving a growing wave of health-motivated expats.
Budesonide–formoterol reliever therapy significantly reduces airway inflammation vs SABA in adults with mild to moderate asthma using ICS.
2don MSN
Eli Lilly launches new form of obesity drug Zepbound with a month’s worth of doses in one pen
Eli Lilly hopes the device can be more convenient for Zepbound users and lead to more people taking the drug.
Inhaled corticosteroids are strongly recommended, in addition to streamlined management with combination and step-up therapy.
Upstream Bio, Inc. downgraded despite strong Verekitug phase 2 asthma results; assess anti-TSLP competition, dosing edge & catalysts. Click for this UPB update.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results